{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:32:44Z","timestamp":1777858364155,"version":"3.51.4"},"reference-count":61,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Clinical trials demonstrate that psychedelic-assisted therapy can improve mental health outcomes; however, few studies have recruited sexually diverse samples or reported information on sexual identity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The purpose of this analysis was to examine the relationship between hallucinogen use and mental health outcomes with respect to sexual identity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a cross-sectional analysis using data from the 2021 National Survey on Drug Use and Health to examine the relationship between hallucinogen use and psychological distress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In a sample representative of 253,824,662 U.S. adults, the majority was heterosexual (92%), aged 50\u201364 (25%), women (51%), non-Hispanic White (62%), college educated (31%), and had an annual household income of $75,000 or higher (39%). The majority reported no lifetime hallucinogen use (82%) and no past month severe psychological distress (93%). Sexual identity modified the relationship between hallucinogen use and psychological distress. After stratifying by sexual identity and adjusting for covariates, hallucinogen use was associated with reduced odds of psychological distress in the heterosexual population (OR\u2009=\u20090.76, 95% CI: 0.59, 0.96) but the relationship was not significant in the sexual minority population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We found that in a nationally representative sample, psychedelic use was associated with reduced odds of psychological distress in heterosexual individuals only. Future research should investigate why hallucinogen use was not protective in sexual minority groups given their disproportionate burden of poor mental health outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811241278774","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:07:46Z","timestamp":1727111266000},"page":"861-872","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4590-4072","authenticated-orcid":false,"given":"Blair","family":"Altman","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Milken Institute School of Public Health at the George Washington University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manya","family":"Magnus","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Milken Institute School of Public Health at the George Washington University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"bibr1-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100538"},{"key":"bibr2-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016025"},{"key":"bibr3-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118798610"},{"key":"bibr4-02698811241278774","unstructured":"Belser A (2019) 10 calls to action: Toward an LGBTQ-affirmative psychedelic therapy. In: Chacruna Institute for Psychedelic Plant Medicines. Available at: https:\/\/chacruna.net\/10-calls-to-action-toward-an-lgbtq-affirmative-psychedelic-therapy\/"},{"key":"bibr5-02698811241278774","volume-title":"Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine","author":"Belser A","year":"2022"},{"key":"bibr6-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118754710"},{"key":"bibr7-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.920117"},{"key":"bibr8-02698811241278774","unstructured":"Chacruna Institute for Psychedelic Plant Medicines (2018) Queering psychedelics. Available at: https:\/\/chacruna.net\/queering-psychedelics\/ (accessed 23 July 2023)."},{"key":"bibr9-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1111\/josi.12233"},{"key":"bibr10-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2019.017"},{"key":"bibr11-02698811241278774","unstructured":"Christ C, Bartlett A, Manoni-Millar S, et al. (2021) The future is queer imagining queer-affirming MDMA-assisted therapy, 2021. Available at: https:\/\/maps.org\/news\/bulletin\/the-future-is-queer-imagining-queer-affirming-mdma-assisted-therapy\/ (accessed 9 September 2023)."},{"key":"bibr12-02698811241278774","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00650"},{"key":"bibr13-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881121991822"},{"key":"bibr14-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2019.015"},{"key":"bibr15-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"bibr16-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1037\/a0025424"},{"key":"bibr17-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2019.1662811"},{"key":"bibr18-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"bibr19-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109610"},{"key":"bibr20-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115598338"},{"key":"bibr21-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565653"},{"key":"bibr22-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.07.004"},{"key":"bibr23-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08085-4"},{"key":"bibr24-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221127304"},{"key":"bibr25-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06580-2"},{"key":"bibr26-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211066714"},{"key":"bibr27-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211058923"},{"key":"bibr28-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18645-3"},{"key":"bibr29-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-8-70"},{"key":"bibr30-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231158245"},{"key":"bibr31-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063972"},{"key":"bibr32-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196312000-00007"},{"key":"bibr33-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/15579883231176646"},{"key":"bibr34-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2608"},{"key":"bibr35-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnaa069"},{"key":"bibr36-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.129.5.674"},{"key":"bibr37-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-1824-6"},{"key":"bibr38-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01336-3"},{"key":"bibr39-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2011.605671"},{"key":"bibr40-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00662-0"},{"key":"bibr41-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117691453"},{"key":"bibr42-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12581"},{"key":"bibr43-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1080\/19359705.2019.1568946"},{"key":"bibr44-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1002\/ajcp.12482"},{"key":"bibr45-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.12.023"},{"key":"bibr46-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117715596"},{"key":"bibr47-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/09727531221120356"},{"key":"bibr48-02698811241278774","first-page":"29","volume":"120","author":"Sobule R","year":"2023","journal-title":"Missouri Med"},{"key":"bibr49-02698811241278774","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.932605"},{"key":"bibr50-02698811241278774","unstructured":"Substance Abuse and Mental Health Services Administration (2023) Lesbian, gay, and bisexual behavioral health: Results from the 2021 and 2022 National Surveys on Drug Use and Health (SAMHSA Publication No. PEP23-07-01-001). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Available at: https:\/\/www.samhsa.gov\/data\/report\/LGB-Behavioral-Health-Report-2021-2022 (accessed 26 July 2023)."},{"key":"bibr51-02698811241278774","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality (2022) 2021 National Survey on Drug Use and Health Public Use File Codebook, Substance Abuse and Mental Health Services Administration. Rockville, MD. Available at: https:\/\/www.datafiles.samhsa.gov\/sites\/default\/files\/field-uploads-protected\/studies\/NSDUH-2021\/NSDUH-2021-datasets\/NSDUH-2021-DS0001\/NSDUH-2021-DS0001-info\/NSDUH-2021-DS0001-info-codebook.pdf (accessed 23 July 2023)."},{"key":"bibr52-02698811241278774","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality (2023a) 2021 National Survey on Drug Use and Health (NSDUH) Methodological Resource Book, Section 13: Statistical inference report. Substance Abuse and Mental Health Services Administration. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt41913\/2021NSDUHmrbStatInference.pdf (accessed 23 July 2023)."},{"key":"bibr53-02698811241278774","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality (2023b) 2023 National Survey on Drug Use and Health (NSDUH): Final In-Person Specifications for Programming (English Version). Rockville, MD. Available at: https:\/\/www.samhsa.gov\/data\/report\/nsduh-2023-questionnaire (accessed 6 October 2023)."},{"key":"bibr54-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2021.1897331"},{"key":"bibr55-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1593559"},{"key":"bibr56-02698811241278774","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1134454"},{"key":"bibr57-02698811241278774","doi-asserted-by":"publisher","DOI":"10.4172\/2161-1165.1000227"},{"key":"bibr58-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-024-02023-y"},{"key":"bibr59-02698811241278774","doi-asserted-by":"publisher","DOI":"10.1177\/20503245231184638"},{"key":"bibr60-02698811241278774","first-page":"215","volume":"28","author":"Williams MT","year":"2021","journal-title":"Drugs (Abingdon, England)"},{"key":"bibr61-02698811241278774","volume":"83","author":"Zeifman RJ","year":"2022","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811241278774","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811241278774","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811241278774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:51Z","timestamp":1777507911000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811241278774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1177\/02698811241278774"],"URL":"https:\/\/doi.org\/10.1177\/02698811241278774","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}